Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Tess Romero, and I'm one of the senior biotech analysts here at JPMorgan. Our next presenting company is Agios, and ...
The fair value estimate for Agios Pharmaceuticals has shifted from US$32.13 to US$36.00, even though the discount rate in the model sits at roughly the same 7.05%. That move reflects updated revenue ...
) has been revised to $39.20 / share. This is an increase of 19.62% from the prior estimate of $32.77 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular ...
Do you like bingo? Lots of bingo events on the horizon in Delco! Do you enjoy parades? Get ready for the 2026 St. Patrick's Parade in Springfield!
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results